Literature DB >> 22654094

Minimal coronary artery damage by myocardial electroporation ablation.

Bastiaan C du Pré1, Vincent J van Driel, Harry van Wessel, Peter Loh, Pieter A Doevendans, Roel Goldschmeding, Fred H Wittkampf, Aryan Vink.   

Abstract

AIMS: Radiofrequency catheter ablation is a successful treatment for cardiac arrhythmias, but may lead to major complications such as permanent coronary damage. Irreversible electroporation (IRE) is a new non-thermal ablation modality, but its effect on coronary arteries is still unknown. METHODS AND
RESULTS: In a porcine model, epicardial IRE lesions were created at the base of the left ventricle in four hearts (group A) and directly on the left anterior descending artery (LAD) in five hearts (group B). After 3 weeks, coronary arteries inside IRE lesions and in apparently undamaged myocardium next to the lesions were (immuno-)histologically studied. Two untreated hearts served as controls. Coronary damage was defined as intimal hyperplasia. Left anterior descending artery angiograms were obtained before ablation, directly after ablation, and before termination in group B. In group A, 103 arterial branches were studied. Of these, 5 of 56 arterial branches inside lesions and 1 of 47 outside lesions showed intimal hyperplasia, but all had <50% area stenosis. Targeted LADs (group B) did not reveal intimal hyperplasia and angiograms showed no signs of stenosis. Expression of connective tissue growth factor was observed in the scar tissue, but not in the fibrotic tissue directly around the arteries, confirming that the arteries are indeed spared from tissue damage and remodelling.
CONCLUSION: Coronary arteries remain free of clinically relevant damage 3 weeks after epicardial IRE ablation, even amid very large myocardial lesions. This suggests that IRE ablation can be applied safely near or even on coronary arteries. With IRE ablation, arterial blood flow does not appear to affect lesion formation.

Entities:  

Mesh:

Year:  2012        PMID: 22654094     DOI: 10.1093/europace/eus171

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  11 in total

Review 1.  Better Lesion Creation And Assessment During Catheter Ablation.

Authors:  Saurabh Kumar; Chirag R Barbhaiya; Samuel Balindger; Roy M John; Laurence M Epstein; Bruce A Koplan; Usha B Tedrow; William G Stevenson; Gregory F Michaud
Journal:  J Atr Fibrillation       Date:  2015-10-31

2.  Optimization of Irreversible Electroporation Protocols for In-vivo Myocardial Decellularization.

Authors:  Yaniv Zager; David Kain; Natalie Landa; Jonathan Leor; Elad Maor
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

3.  Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study.

Authors:  Steffi J E Rombouts; Maarten W Nijkamp; Willemijn P M van Dijck; Lodewijk A A Brosens; Maurits Konings; R van Hillegersberg; Inne H M Borel Rinkes; Jeroen Hagendoorn; Fred H Wittkampf; I Quintus Molenaar
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 4.  Innovations in Clinical Cardiac Electrophysiology: Challenges and Upcoming Solutions in 2018 and Beyond.

Authors:  Vaibhav R Vaidya; Alan Sugure; Samuel J Asirvatham
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

5.  Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation.

Authors:  Jacob S Koruth; Kenji Kuroki; Jin Iwasawa; Raju Viswanathan; Richard Brose; Eric D Buck; Elina Donskoy; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  Europace       Date:  2020-03-01       Impact factor: 5.214

Review 6.  Pulsed Field Ablation to Treat Atrial Fibrillation: A Review of the Literature.

Authors:  Antonio Di Monaco; Nicola Vitulano; Federica Troisi; Federico Quadrini; Imma Romanazzi; Valeria Calvi; Massimo Grimaldi
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-24

7.  Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro.

Authors:  Jara M Baena-Montes; Tony O'Halloran; Cormac Clarke; Kevin Donaghey; Eoghan Dunne; Martin O'Halloran; Leo R Quinlan
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28

8.  Open-chest Pulsed Electric Field Ablation of Cardiac Ganglionated Plexi in Acute Canine Models.

Authors:  Martin van Zyl; Mariam Khabsa; Jason A Tri; Thomas P Ladas; Omar Z Yasin; Adetola O Ladejobi; John Reilly; Barry O'Brien; Kenneth Coffey; Samuel J Asirvatham
Journal:  J Innov Card Rhythm Manag       Date:  2022-07-15

9.  Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability.

Authors:  Christopher Livia; Alan Sugrue; Tyra Witt; Murray D Polkinghorne; Elad Maor; Suraj Kapa; Helge I Lehmann; Christopher V DeSimone; Atta Behfar; Samuel J Asirvatham; Christopher J McLeod
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

10.  Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation.

Authors:  Jacob Koruth; Kenji Kuroki; Jin Iwasawa; Yoshinari Enomoto; Raju Viswanathan; Richard Brose; Eric D Buck; Molly Speltz; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.